Investment Q&A

Q: Hello 5i team I am building a US stock portfolio and would like your opinion on the stocks I wish to accumulate. jpm,t,psx,jnj,nvda,tot. I plan on buying these over 6-8 month period and holding for 3-5 yrs. I am trying to into get into different industries and picking some best of breeds. I would also like to add 2-3 etf (1-growth,1-income,1-balanced)if you could recommend some to compliment these stocks. Thks

Q: Is your opinion on Div still positive ?

Q: My financial advisor recently proposed this company for my rsp your thoughts please

Q: I have not completed filling out the model and income portfolios. I would appreciate it if you could suggest the top 5 to purchase now in each portfolio based on a risk/reward analysis.

Thanks again.

Q: I am re-balancing my portfolios this week and wondering which 6 stocks from the Balanced Equity model portfolio would be your top picks at the moment? Let's assume 3-5 years time frame here.
Thanks.

Q: Hi Team - I have CNR and WSP and want to add one chem to round out my Industrials. SPB or CHE.un? thanks

Q: An update please on Enerplus as a potential takeover candidate. Thanks!

Q: Your thoughts on ZRE and CPD at this moment. Are they a buy?
Thanks

Q: Good Day Peter & Co.
I own 3500 units of AAR.UN in my TFSA. I have owned it since their IPO several years ago.For the last couple of years their dividend payout ratio has been creeping up According to The Globe & Mail payout ratio calculation, AAR's payout ratio is 108.30%. Do you agree with their calculation? If so, should I be selling some or all of my holding.
Many thanks for your valued opinion.

Q: Hi Peter, I own BTE and my cost is 26.51 if I were to buy 100 more shares it would get the cost down to about 16.00. Would this gamble be wise, waiting for oil to rebound, and if it were to be bought at what price might it be bought at. I know you can't predict the price but what value might it have at this point. Thanks

Q: I have an account with BMOInvestorline. With this,I receive ratings changes from Ford Equity Research. I have received a notice that Ford has changed the rating on DHX from Hold to Sell. Do you have any insight as to why? How do you view DHX for a long term hold for growth? Thank you.

Q: Hello 5i,
Recently you mentionned that gic's might do just as well as a bond fund in this environment. I notice that a five year latter is mentionned often. Under current conditions, i have wondered whether, say, a three year ladder wouldn't be better. What are your thoughts on that? I imagine people suggest five years because it gives a bit more income. But, it also locks you in for a longer period
Thanks

Q: Could you comment on the Killam proposal to convert from corp to REIT. What are the pros and cons to a shareholder, and in general, do you see this as a positive move?

Thank-you

Q: Mitel Networks in my thinking has been a growth company for sometime. Did you even consider it for your growth portfolio? With the current valuation and the activist interest do you think it is worth taking a position here?

Q: Hello Peter,
Regards your response to a question today, swould the increase in credit spreads on its debt affect its ability to raise the $950 million, or make the terms for the debt unfavorable for the company thereby impacting the bottomline for the next 6to 8 quarters? Has the risk increased and the probability of a bounce reduced thereby making the current price appropriate rather than attractive?
Regards
Rajiv

Q: Hi Peter, I have to confess that I became too greedy today and bought 5% of my portfolio at 45.20. In retrospect now I am thinking I took probably too much risk. I started buying CXR at CAD 86 and then bought some at CAD 65 and again some at CAD 50 and today CAD 45.20. Now it is 15% of my taxable account portfolio. My average cost is now at around CAD 55. Should I see some position?

I read TD Securities report and they have a Price Target at CAD $105. I read RBC report too and they have USD $86 target price(in their worst model it is USD $30). Also read Jason Donneville letter. Anyways reading at the reports and looking at your responses since 2014 for this company it seems to me it is significantly undervalued. As say 4.6X 2017 earnings(that is a PE a Bank deserves during a financial meltdown). So I am not sure what I am missing here. I know they have high debt load, but looking at their current debt to equity ratio(I got it from TD, can you please confirm from Bloomberg? Also I believe this is pre-amdipharm number), it is lower than Valeant. Anyways, considering healthcare earnings estimates are usually accurate(i meant not in vagary of economic downturn), what is the major problem here(that retail investor like me don't know)? Can you please jot down the risks? Also is there any possibility that they could not acquire amdipharm? Can you tell me from Bloomberg if any institutional selling recently? Can you elaborate on that? Also being a very popular stock why don't you guys please start coverage on it? Also what is your earnings target for this in 2017?

Q: I sold Wajax & Transalta. Can you please advise your best picks for replacements for these. Combination of dividend and growth is nice but primarily which have the most future upside in a recovery?

Q: Hi Peter, Can you please comment on the safety of GICs in Achieva Financial Credit Union in Manitoba? The website says its deposits are protected by Manitoba credit union deposit protection. How does that compare with CDIC deposit protection? My accountant swears by it and has money in it.

Q: Hi,

This stock seems to have lost its momentum compared to its peers. I have made good money on this and wonder if it's time to get out? I can't afford another AVO. What are your thoughts?

Q: This stock appears very volatile for a consumer staples. what are your views on short and long term outlook for this company?

I have small position at about $52. Is it sell, hold or add more at current levels?
thanks